To the full analysis
Buyback calculator for HCA Healthcare
HCA Healthcare stock: key metrics
HCAHCA Healthcare had an operating margin of 15.8% and a return on invested capital (ROIC) of 21% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 83.0% | 11.1% | 4.1% |
| 2007 | 83.6% | 11.0% | 3.3% |
| 2008 | 83.7% | 10.3% | 2.4% |
| 2009 | 83.8% | 12.6% | 3.5% |
| 2010 | 75.2% | 13.6% | 3.9% |
| 2011 | 75.4% | 13.3% | 7.6% |
| 2012 | 82.7% | 14.6% | 4.9% |
| 2013 | 82.5% | 14.0% | 4.6% |
| 2014 | 83.0% | 15.1% | 5.1% |
| 2015 | 83.3% | 15.0% | 5.4% |
| 2016 | 83.3% | 14.9% | 7.0% |
| 2017 | 83.2% | 13.9% | 5.1% |
| 2018 | 83.5% | 14.2% | 8.1% |
| 2019 | 83.5% | 14.1% | 6.8% |
| 2020 | 83.8% | 14.1% | 7.3% |
| 2021 | 38.3% | 16.5% | 11.8% |
| 2022 | 38.5% | 15.0% | 9.4% |
| 2023 | 39.4% | 14.8% | 8.1% |
| 2024 | 40.6% | 14.9% | 8.2% |
| 2025 | 41.5% | 15.8% | 9.0% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | −9.1% | 10.2% | 4.4% |
| 2007 | −8.3% | 12.5% | 3.6% |
| 2008 | −6.6% | 13.1% | 2.8% |
| 2009 | −11.7% | 15.1% | 4.4% |
| 2010 | −10.1% | 17.1% | 5.1% |
| 2011 | −29.8% | 18.9% | 9.2% |
| 2012 | −16.6% | 16.9% | 5.7% |
| 2013 | −18.8% | 15.9% | 5.4% |
| 2014 | −23.8% | 17.5% | 6.0% |
| 2015 | −28.0% | 17.6% | 6.5% |
| 2016 | −39.6% | 18.1% | 8.6% |
| 2017 | −32.6% | 14.5% | 6.1% |
| 2018 | −76.5% | 19.3% | 9.7% |
| 2019 | −100.0% | 17.9% | 7.8% |
| 2020 | 200.0% | 17.1% | 7.9% |
| 2021 | −100.0% | 21.4% | 13.7% |
| 2022 | −100.0% | 19.0% | 10.8% |
| 2023 | −100.0% | 18.7% | 9.3% |
| 2024 | −100.0% | 19.2% | 9.7% |
| 2025 | −100.0% | 21.0% | 11.2% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 5 Nov 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.